Trulieve publishes investor presentation outlining US medical cannabis footprint and growth catalysts

Trulieve Cannabis Corp.
TRULITE INC

Trulieve Cannabis Corp.

TRLV

0.00

TRULITE INC

TRUL

0.00
  • Trulieve highlighted its NYSE listing under ticker TRLV on June 10, 2026, following federal medical marijuana rescheduling to Schedule III in April 2026.
  • Outlined a June 3, 2026 restructuring that deconsolidated “Harvest” mixed-use operations to support the NYSE move; Trulieve retains 90% economic interest.
  • Core consolidated footprint framed as DEA-registered, medical-only operations: 206 dispensaries, 3.5 million square feet of cultivation and processing capacity.
  • Reiterated 2025 consolidated results: USD 1.2 billion revenue, 60% gross margin, USD 273 million cash flow from operations.
  • Flagged near-term growth focus in Georgia, Texas; cited potential tax relief from removal of 280E burden under Schedule III treatment.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Trulieve Cannabis Corp. published the original content used to generate this news brief on June 12, 2026, and is solely responsible for the information contained therein.

This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.